Finance entity
markets is the sole category represented across all 2 tracked stories. Medpace is most often covered alongside AeroVironment, which appears in 2 of these 2 stories. The 5 average consequence score is below the beat benchmark of 6.3 in the same window.
Last mentioned: Feb 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 2 tracked stories. Medpace is most often covered alongside AeroVironment, which appears in 2 of these 2 stories. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Medpace appears in 2 tracked Finance stories from February 20, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 75 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Medpace. Shared-story counts are live from our verified record — not editorial picks.
American Capital Management has significantly increased its position in Proto Labs, acquiring over 350,000 shares in the fourth quarter of 2025. The move comes as the digital manufacturer outperforms the S&P 500 by nearly 40 percentage points, signaling strong institutional confidence in on-demand industrial technology.
Source: Jake Lerch (us) · fool.com
American Capital Management Inc. nearly doubled its position in Novanta (NOVT) during the fourth quarter of 2025, adding 163,005 shares. The $18.56 million trade boosts the firm's total holding to over $45 million, signaling a contrarian bet on the precision motion specialist despite its recent market underperformance.
Source: Jake Lerch (us) · finance.yahoo.com
Medpace is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
